| Literature DB >> 32576045 |
Changlin Li1, Le Zhou1, Gianlorenzo Dionigi2, Fang Li1, Yishen Zhao1, Hui Sun1.
Abstract
Purpose. We examined the relationships between tumor tissue calcifications of papillary thyroid cancer (PTC), body mass index (BMI), and tumor invasiveness. Methods. This is a retrospective analysis of 13,995 patients with PTC. Comparisons were made between the clinical and pathological features of the tumor tissue calcifications group and non-tumor tissue calcifications group. The odds ratios (OR) of tumor tissue calcifications, BMI, and tumor invasiveness features were calculated using a binary logistic regression model. We analyzed the relationship between tumor tissue calcifications, and certain characteristics of thyroid cancer based on the pathological findings. Results. BMI was positively correlated with tumor tissue calcifications in patients with PTC (OR=1.015, P=0.011), and obesity increased risk of tumor tissue calcifications (OR = 1.374, P=0.038). Calcifications were positively correlated with T-size (OR=1.899, P<0.001), multifocality (OR = 1.217, P<0.001), extra thyroidal extension (ETE) (OR = 1.287, P<0.001), high T-stage (OR = 1.765, P<0.001), N+ (OR = 1.763, P<0.001), and a higher number of lymph node metastases (OR=1.985, P<0.001). Compared with normal-weight patients with tumor tissue calcifications, the obese patients with tumor tissue calcifications had an increased risk of ETE (OR obesity = 1.765 vs. OR normal = 1.300) and N+ (OR obesity = 1.992 vs. OR normal = 1.784). Conclusions. Tumor tissue calcifications are positively correlated with the invasiveness of PTC. Obesity further promotes the risk of tumor invasiveness in PTC combined with tumor tissue calcifications. These findings suggest that more comprehensive evaluations by trained pathologists may help physicians identify the optimal therapeutic regimens in the postoperative period.Entities:
Keywords: Papillary thyroid cancer; body mass index; pathological features; tumor invasive growth; tumor tissue calcification; ultrasonography
Year: 2020 PMID: 32576045 DOI: 10.4158/EP-2020-0057
Source DB: PubMed Journal: Endocr Pract ISSN: 1530-891X Impact factor: 3.443